Home / Stocks / DMAC

DMAC insider trading

DiaMedica Therapeutics Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
5
Bought · 24 mo
$30.4M
Buys · last 90 days
0 · $0
Most recent buy
2025-12-08

Recent insider filings

FiledInsiderTypeSharesPriceValue
2025-12-08STAHLBERG JAN
10% owner
Bought1,061,277$7.19$7.6M
2025-09-04STAHLBERG JAN
10% owner
Bought1,000,000$5.96$6.0M
2025-07-25STAHLBERG JAN
10% owner
Bought1,542,857$3.50$5.4M
2025-07-25TomEnterprise AB
10% owner
Bought2,857,142$3.50$10.0M
2025-07-25JACINTO RICHARD II
10% owner
Bought400,000$3.50$1.4M

Most active insider buyers

InsiderRoleBuysTotal bought
STAHLBERG JAN10% owner3$19.0M
TomEnterprise AB10% owner1$10.0M
JACINTO RICHARD II10% owner1$1.4M

See DMAC on the chart

Every insider buy and sell for DMAC plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.